Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Veristat Blog

Evolving Risk-Based Monitoring to Improve Clinical Studies

An Interview with Dunya Botetzayas, RN, Senior Director of Clinical Monitoring at Veristat

Regulatory Guidance Monthly Review - September 2019

September 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a...

What Matters Most in the Clinical Study Feasibility Process

Site Selection to Protocol Development: An Approach to the Feasibility Process

How does the site...

Regulatory Guidance Monthly Review - August 2019

August 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection...

Regulatory Guidance Monthly Review - July 2019

July 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection...

Regulatory Guidance Monthly Review - June 2019

June 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection...

Regulatory Guidance Review - May 2019

May 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of...

Regulatory Guidance Review - April 2019

Latest Updates from FDA & EMA

April 2019 Updates

Each month, Veristat's regulatory team tracks and...

5 Ways To Transform Your Workspace For Inspiration and Creativity

It’s mid-afternoon on a Thursday, and you’re at your desk. You have important work to do, but your...

Regulatory Guidance Review

Latest Updates from FDA & EMA

March 2019

Each month, Veristat's regulatory team tracks and shares...